During the past decade, Houston Metro Urology conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 6 clinical trials were completed, i.e. on average, 26.1% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 6 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Houston Metro Urology" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Pfizer" with 4 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored, "Allena Pharmaceuticals" with 2 trials sponsored and "Veru Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Houston Metro Urology" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Houston Metro Urology" are "Enteric Hyperoxaluria" (3 trials), "Prostate Cancer" (2 trials), "Prostatic Neoplasms" (2 trials), "Advanced Prostate Adenocarcinoma" (1 trials) and "Androgen Resistant Prostatic Cancer" (1 trials). Many other conditions were trialed in "Houston Metro Urology" in a lesser frequency.

Most popular intervention types in "Houston Metro Urology" are "Drug" (16 trials), "Device" (5 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Apalutamide" (2 trials), "Niraparib" (2 trials), "Prednisone" (2 trials) and "177Lu-PSMA-I&T" (1 trials). Other intervention names were less common.

The vast majority of trials in "Houston Metro Urology" are 16 trials for "Male" genders, 6 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Houston Metro Urology". undefined are not yet recruiting, 4 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Houston Metro Urology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Houston Metro Urology, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".